Triaging HPV-Positive Cervical Samples with p16 and Ki-67 Dual Stained Cytology within an Organized Screening Program—A Prospective Observational Study from Western Norway
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24087158 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Irene Tveiterås Øvestad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Stavanger University Hospital, 4011 Stavanger, Norway. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Uterine Cervical Dysplasia, Papillomavirus Infections. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The implementation of high-risk human papillomavirus testing (hrHPV testing) as a screening method in substitute for cytology has evoked the need for more sensitive and less objective tests for the triage of HPV-positive women. In a cohort of 1763 HPV-positive women, the potential of immunocytochemical p16 and Ki-67 dual staining as compared to cytology, alone or in combination with HPV partial genotyping, was tested for triage of women attending a cervical cancer screening program. Performance was measured using sensitivity, specificity, and positive and negative predictive values. Comparisons were assessed using logistic regression models and the McNemar test. Dual staining was evaluated in a prospectively collected study cohort of 1763 HPV-screened women. For triage of CIN2+ and CIN3+, NPV and sensitivity, 91.8% and 94.2% versus 87.9% and 89.7%, respectively, were significantly higher using dual staining together with HPV 16/18 positive, as compared to cytology (p < 0.001). The specificities, however, were lower for dual staining as compared to cytology. Conclusions: Dual staining is safer for decision-making regarding HPV-positive women’s need for follow-up with colposcopy and biopsy, as compared to cytology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Stavanger University Hospital, 4011 Stavanger, Norway.
- Department of Research, Stavanger University Hospital, 4011 Stavanger, Norway.
- Department of Pathology, Haukeland University Hospital, 5053 Bergen, Norway.
- Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, 5020 Bergen, Norway.
- Department of Chemistry, Bioscience and Environmental Technology, University of Stavanger, 4021 Stavanger, Norway.
ORCID-Profile: Ingvild Dalen, Emilius A M Janssen
Zitieren
APA
Øvestad, I. T., Dalen, I., Andersland, M. S., Vintermyr, O. K., Moltu, P., Berland, J. M., Janssen, E. A. M., & Haugland, H. K. (2023). Triaging HPV-Positive Cervical Samples with p16 and Ki-67 Dual Stained Cytology within an Organized Screening Program—A Prospective Observational Study from Western Norway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24087158
Vancouver
Øvestad IT, Dalen I, Andersland MS, Vintermyr OK, Moltu P, Berland JM, et al. Triaging HPV-Positive Cervical Samples with p16 and Ki-67 Dual Stained Cytology within an Organized Screening Program—A Prospective Observational Study from Western Norway. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24087158
BibTeX
@article{vestad2023,
author = {Øvestad, Irene Tveiterås and Dalen, Ingvild and Andersland, Marie S and Vintermyr, Olav K and Moltu, Pia and Berland, Jannicke M and Janssen, Emilius A M and Haugland, Hans Kristian},
title = {Triaging HPV-Positive Cervical Samples with p16 and Ki-67 Dual Stained Cytology within an Organized Screening Program—A Prospective Observational Study from Western Norway},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24087158}
}
EUVIMED